Black Rock Inc. Dice Therapeutics, Inc. Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$25.86 - $46.71 $3.03 Million - $5.47 Million	-117,134 Reduced 3.89%	2,895,307 $135 Million
Q1 2023 May 12, 2023	SELL	$26.05 - $32.31 $1.03 Million - $1.28 Million	-39,661 Reduced 1.3%	3,012,441 $86.3 Million
Q4 2022 Feb 13, 2023	BUY	$19.77 - $42.23 $22.6 Million - $48.4 Million	1,145,411 Added 60.07%	3,052,102 $95.2 Million
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $2.81 Million - $4.26 Million	187,979 Added 10.94%	1,906,691 $38.7 Million
Q2 2022 Aug 12, 2022	BUY	$13.19 - $22.1 $11.3 Million - $19 Million	858,172 Added 99.72%	1,718,712 $26.7 Million
Q1 2022 May 12, 2022	BUY	$14.54 - $25.02 $76,262 - $131,229	5,245 Added 0.61%	860,540 $16.5 Million
Q4 2021 Feb 10, 2022	BUY	$22.41 - $37.54 $19.2 Million - $32.1 Million	855,295 New	855,295 $21.6 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.